Applied Clinical Trials Online

FDA releases 14 drug rejection letters after 3-month pause

The FDA has resumed the release of pharma rejection letters, issuing 14 Complete Response Letters (CRLs) following a three-month disclosure freeze.

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks